PLA2R1 and acute lymphoblastic leukemia: Taken together, our findings support the hypothesis, initially established from the obtained data in adult patients with AML19, that the determination of PLA2R1 methylation may be also a sensitive marker for treatment efficacy and monitoring of minimal residual disease in childhood ALL.